Trexquant Investment’s Tarsus Pharmaceuticals TARS Stock Holding History

Trexquant Investment’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.78M	Buy	44,152 +20,491	+87%	+$1.31M	0.02%	1044
2026 Q1	$1.66M	Sell	23,661 -30,885	-57%	-$2.16M	0.01%	1063
2025 Q4	$4.47M	Buy	54,546 +34,542	+173%	+$2.58M	0.04%	649
2025 Q3	$1.19M	Sell	20,004 -74,620	-79%	-$3.67M	0.01%	1087
2025 Q2	$3.83M	Buy	+94,624	New	+$4.26M	0.04%	636
2024 Q3	–	Sell	-34,903	Closed	-$949K	–	1846
2024 Q2	$949K	Sell	34,903 -6,135	-15%	-$206K	0.01%	1015
2024 Q1	$1.49M	Buy	41,038 +1,541	+4%	+$45.3K	0.03%	758
2023 Q4	$800K	Buy	+39,497	New	+$660K	0.02%	903

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Trexquant Investment's TARS Position: Q2 2026 in Review

Trexquant Investment increased its Tarsus Pharmaceuticals (TARS) stake by 87% in Q2 2026, buying an estimated $1.31M and bringing the position to 44,152 shares worth $2.78M. The position accounts for 0.02% of the portfolio, ranked #1044.

Trexquant Investment first reported a position in TARS in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.47M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Trexquant Investment held 44,152 shares of Tarsus Pharmaceuticals worth $2.78M as of Q2 2026.
Trexquant Investment bought 20,491 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $1.31M.
Tarsus Pharmaceuticals made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1044 holding.
Trexquant Investment first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
Trexquant Investment's Tarsus Pharmaceuticals position peaked at $4.47M in Q4 2025.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.